Table 2.
R | Lo | Mo | Hi | R | Lo | Mo | Hi | R | Lo | Mo | Hi | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DAS28-ESR | 17 | 1* | 1* | 0* | 12 | 6* | 1* | 0* | 12 | 6* | 1* | 0* | R |
19* | 9 | 1* | 0* | 7* | 20 | 2* | 0* | 5* | 23 | 1* | 0* | Lo | |
4* | 13* | 59 | 1* | 1* | 26* | 44 | 6* | 0* | 23* | 50 | 4* | Mo | |
0* | 0* | 26* | 24 | 0* | 0* | 13* | 37 | 0* | 0* | 19* | 31 | Hi | |
| |||||||||||||
Kappa 0.456 (p<0.001) | DAS28-CRP | 20 | 20* | 0* | 0* | 17 | 23* | 0* | 0* | R | |||
ICC 0.882 | 0* | 18 | 5* | 0* | 0* | 19 | 4* | 0* | Lo | ||||
(0.438, 0.955) | 0* | 14* | 54 | 19* | 0* | 10* | 65 | 12* | Mo | ||||
Agreement 62.3% | 0* | 0* | 1* | 24 | 0* | 0* | 2* | 23 | Hi | ||||
Incompatibility 37.7% | |||||||||||||
| |||||||||||||
Kappa 0.506 | Kappa 0.538 | CDAI | 17 | 3* | 0* | 0* | R | ||||||
(p<0.001) | (p<0.001) | 0* | 48 | 4* | 0* | Lo | |||||||
ICC 0.202 | ICC 0.190 | 0* | 1* | 59 | 0* | Mo | |||||||
(0.055, 0.339) | (0.043, 0.329) | 0* | 0* | 8* | 35 | Hi | |||||||
Agreement 64.6% | Agreement 66.3% | ||||||||||||
Incompatibility 35.4% | Incompatibility 33.7% | ||||||||||||
| |||||||||||||
Kappa 0.5215 | Kappa 0.5887 | Kappa 0.8717 | SDAI | ||||||||||
(p<0.001) | (p<0.001) | (p<0.001) | |||||||||||
ICC 0.194 | ICC 0.183 | ICC 0.975 | |||||||||||
(0.47, 0.332) | (0.36, 0.323) | (0.854, 0.990) | |||||||||||
Agreement 66.3% | Agreement 70.9% | Agreement 90.9% | |||||||||||
Incompatibility 33.7% | Incompatibility 29.1% | Incompatibility 9.1% |
Patients categorized into incompatible categories by two indices. The Kappa coefficient, ICC with its 95% CI levels of agreement, and percentage of incompatibly classified patients are also shown. Cutoff values are based on published criteria (14).
CDAI: clinical disease activity index; CI: confidence interval; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; Hi: high activity; ICC: intra-class coefficient; R: remission; Lo: low activity; Mo: moderate activity; SDAI: simple disease activity index.